<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03394807</url>
  </required_header>
  <id_info>
    <org_study_id>LaGRA-MRHM</org_study_id>
    <nct_id>NCT03394807</nct_id>
  </id_info>
  <brief_title>LaGRA Trial in Laparoscopic Cholecystectomy</brief_title>
  <acronym>LaGRA</acronym>
  <official_title>Laparoscopic Guided Regional Analgesia (LaGRA) Reduces Post Operative Pain After Laparoscopic Cholecystectomy - a Randomised, Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Health Service Executive, Ireland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Health Service Executive, Ireland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigated the effectiveness of a surgeon administered, laparoscopic guided,
      regional anaesthesia technique.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective, double blind, randomised controlled trial was performed. Consenting patients
      undergoing laparoscopic cholecystectomy were randomised, by envelope, to a laparoscopic
      guided 2-point blockade (subcostal transversus abdominis plane and rectus sheath) using
      either ChirocaineÂ® 2.5mg/ml (LaGRA) or 0.9% Saline (Placebo) after specimen extraction.

      Primary endpoints were post-operative pain in the first 6 hours. Secondary endpoints were
      analgesic/anti-emetic usage and day case and re-admission rates. Data was analysed using
      GraphPad Prism (V7).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2016</start_date>
  <completion_date type="Actual">August 30, 2017</completion_date>
  <primary_completion_date type="Actual">July 30, 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective, randomised, placebo controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Blinded</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Post operative pain score</measure>
    <time_frame>6 hours post operatively</time_frame>
    <description>Visual analogue pain scores ranging from 0 to 10</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Opioid use</measure>
    <time_frame>Perioperative period including first 6 hours post operatively</time_frame>
    <description>Amount (mg) of opioid medication administered</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analgesic use</measure>
    <time_frame>Perioperative period including first 6 hours post operatively</time_frame>
    <description>Type and dose of all non opioid analgesic medications prescribed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Readmission rate</measure>
    <time_frame>30 days post operative</time_frame>
    <description>Patient readmitted to hospital for any reason</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daycase rates</measure>
    <time_frame>Day of surgery</time_frame>
    <description>Patient that was planned for daycase but admitted overnight</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">76</enrollment>
  <condition>Regional Anesthesia Morbidity</condition>
  <condition>Gallbladder Stone</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>LaGRA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>regional anaesthesia of the right upper quadrant by injection of levobupivacaine 0.25% to the transversus abdominis plane and the rectus sheath under laparoscopic guidance immediately following specimen removal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Sham regional anaesthesia of the right upper quadrant by injection of Saline 0.9% to the transversus abdominis plane and the rectus sheath under laparoscopic guidance immediately following specimen removal</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine</intervention_name>
    <description>Levobupivacaine injection to Transversus abdominis plane and rectus sheath</description>
    <arm_group_label>LaGRA</arm_group_label>
    <other_name>Chirocaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Saline injection to Transversus abdominis plane and rectus sheath</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing laparoscopic cholecystectomy

          -  ASA I, II or III

        Exclusion Criteria:

          -  Patients that don't consent to be included

          -  Allergy to levobupivacaine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 15, 2017</study_first_submitted>
  <study_first_submitted_qc>January 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 9, 2018</study_first_posted>
  <last_update_submitted>January 8, 2018</last_update_submitted>
  <last_update_submitted_qc>January 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Health Service Executive, Ireland</investigator_affiliation>
    <investigator_full_name>Des Toomey</investigator_full_name>
    <investigator_title>Consultant Surgeon</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholelithiasis</mesh_term>
    <mesh_term>Cholecystolithiasis</mesh_term>
    <mesh_term>Gallstones</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

